KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) EPS (Basic) (2016 - 2025)

Teladoc Health (TDOC) has disclosed EPS (Basic) for 12 consecutive years, with -$0.14 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 46.15% to -$0.14 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.14 through Dec 2025, up 80.55% year-over-year, with the annual reading at -$1.14 for FY2025, 80.58% up from the prior year.
  • EPS (Basic) hit -$0.14 in Q4 2025 for Teladoc Health, up from -$0.28 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.05 in Q4 2021 to a low of -$41.58 in Q1 2022.
  • Historically, EPS (Basic) has averaged -$4.79 across 5 years, with a median of -$0.44 in 2022.
  • Biggest five-year swings in EPS (Basic): plummeted 46920.0% in 2022 and later soared 99.28% in 2023.
  • Year by year, EPS (Basic) stood at -$0.05 in 2021, then tumbled by 46920.0% to -$23.51 in 2022, then skyrocketed by 99.28% to -$0.17 in 2023, then plummeted by 52.94% to -$0.26 in 2024, then surged by 46.15% to -$0.14 in 2025.
  • Business Quant data shows EPS (Basic) for TDOC at -$0.14 in Q4 2025, -$0.28 in Q3 2025, and -$0.19 in Q2 2025.